IQV Stock IQVIA Holdings Inc.
US · NYSELast in our picks 2026-10-05 — not in the current list; analysis below is from that screen
Clinical-trial and data services demand makes this a steady compounder with catalysts.
Future value: $277.94 (+7.64%) · 6-12 months · analyst consensus
Signal breakdown
- ▸Resilient backlog and positive healthcare services momentum.
- ▸Above 50-day MA (+1.74%)
- ▸Above 200-day MA — long-term uptrend
- ▸Near 52-week high (84.4% of range) — strength
Is IQV a buy right now?
Trend: IQV is trading above the 50-day average (+3.65%), RSI 32 — neutral momentum, with a 3-month return of +12.62%.
Valuation & quality: IQVIA Holdings Inc. trades on a trailing P/E of 34.0, forward P/E 19.0, PEG 1.01, price-to-book 7.30; fundamentals show net margin 8.1%, return on equity 22.8%, revenue growth 8.7% year on year.
Analyst consensus: 18 analysts have a mean 12-month price target of $302.67 (+10.6% vs the last close; range $268.00 – $345.00), consensus rating “strong buy”.
Our screen: STRONG BUY (score 4) — Clinical-trial and data services demand makes this a steady compounder with catalysts.
Computed from end-of-day data; not personal advice.
12-month price chart
Monthly returns
| Mar 26 | Apr 26 | May 26 | Jun 26 | Jul 26 | Aug 26 | Sep 26 | Oct 26 |
|---|---|---|---|---|---|---|---|
| -4.60% | -7.10% | +15.10% | +6.00% | +21.60% | +11.10% | +2.90% | +1.80% |
Fundamentals
Analyst price target
Technical signals
About IQVIA Holdings Inc.
IQVIA Holdings Inc. provides clinical research services, commercial insights, and healthcare intelligence to the life sciences and healthcare industries in the Americas, Europe, Africa, and the Asia-Pacific.
Sector: Healthcare · Industry: Diagnostics & Research · United States · 94,000 employees · Website
Related Health Care picks
Browse: all US stocks · Health Care picks · today's movers
Market data from end-of-day feeds; AI-generated research for educational purposes only — not investment advice.